The Phenotypic Consequences of CFTR Mutations

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Annals of Human Genetics

• Publication date

  2003-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1469-1809.2003.00028.xPMID 12940920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cystic Fibrosis

  2009cited by this paper
• Crystal Structure of the ATP binding domain of PrrB from Mycobacterium Tuberculosis

  2005cited by this paper
• DNA polymorphisms in potential regulatory elements of the CFTR gene alter transcription factor binding

  2002cited by this paper
• Determination of the relative contribution of three genes–the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene–to the etiology of idiopathic chronic pancreatitis

  2002cited by this paper
• Listening to silence and understanding nonsense: exonic mutations that affect splicing

  2002cited by this paper
• Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.

  2002cited by this paper
• Can a place of origin of the main cystic fibrosis mutations be identified?

  2002cited by this paper
• Atypical 5' splice sites cause CFTR exon 9 to be vulnerable to skipping.

  2002cited by this paper
• Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis.

  2001cited by this paper
• An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis

  2001cited by this paper
• Mutations of the cystic fibrosis gene in patients with chronic pancreatitis

  2001cited by this paper
• Nuclear factor TDP‐43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping

  2001cited by this paper
• Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings.

  2001cited by this paper
• Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A→G, 2751+2T→A, 296+1G→C, 1717–9T→C-D565G) and one nonsense mutation (E822X) in the CFTR gene

  2001cited by this paper
• Modifier genes and variation in cystic fibrosis

  2001cited by this paper
• Two Mild Cystic Fibrosis-associated Mutations Result in Severe Cystic Fibrosis When Combined in Cis and Reveal a Residue Important for Cystic Fibrosis Transmembrane Conductance Regulator Processing and Function*

  2001cited by this paper
• Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group.

  2001cited by this paper
• Aberrant CFTR-dependent HCO-3 transport in mutations associated with cystic fibrosis

  2001cited by this paper
• Splicing Factors Induce Cystic Fibrosis Transmembrane Regulator Exon 9 Skipping through a Nonevolutionary Conserved Intronic Element*

  2000cited by this paper
• A Naturally Occurring Sequence Variation That Creates a YY1 Element Is Associated with Increased Cystic Fibrosis Transmembrane Conductance Regulator Gene Expression*

  2000cited by this paper
• Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis

  2000cited by this paper
• TGF-β1 genotype and accelerated decline in lung function of patients with cystic fibrosis

  2000cited by this paper
• Fetal bowel hyperechogenicity may indicate mild atypical cystic fibrosis: a case associated with a complex CFTR allele

  2000cited by this paper
• Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion.

  2000cited by this paper
• Cystic Fibrosis Transmembrane Conductance Regulator

  2000cited by this paper
• Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes.

  2000influential reference
• Cystic fibrosis transmembrane regulator ( CFTR ) (cid:196) F508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer

  2000cited by this paper
• Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population.

  2000cited by this paper
• Genotype and Phenotype in Cystic Fibrosis

  2000cited by this paper
• Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9.

  1999cited by this paper
• Apport de la génétique

  1999cited by this paper
• CFTR is a conductance regulator as well as a chloride channel.

  1999cited by this paper
• DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis.

  1999cited by this paper
• A perfect message: RNA surveillance and nonsense-mediated decay.

  1999cited by this paper
• First putative sequence alterations in the minimal CFTR promoter region

  1999cited by this paper
• ΔF508 CFTR protein expression in tissues from patients with cystic fibrosis

  1999cited by this paper
• C-terminal Truncations Destabilize the Cystic Fibrosis Transmembrane Conductance Regulator without Impairing Its Biogenesis

  1999cited by this paper
• Missense mutations in the cystic fibrosis gene in adult patients with asthma

  1999cited by this paper
• Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13

  1999cited by this paper
• Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis.

  1999cited by this paper
• Mutations of the cystic fibrosis gene in patients with chronic pancreatitis.

  1998cited by this paper
• Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.

  1998cited by this paper
• Salmonella typhi uses CFTR to enter intestinal epithelial cells

  1998cited by this paper
• Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis

  1998cited by this paper
• Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator.

  1998cited by this paper
• Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.

  1998cited by this paper
• The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation.

  1998cited by this paper
• Analysis of the CFTR gene in Turkish cystic fibrosis patients: identification of three novel mutations (3172delAC, P1013L and M1028I)

  1998influential reference
• Characterization of mutations located in exon 18 of the CFTR gene

  1998cited by this paper
• Alpha1-antitrypsin deficiency alleles and the Taq-I G-->A allele in cystic fibrosis lung disease.

  1998cited by this paper
• Crystal structure of the ATP-binding subunit of an ABC transporter

  1998cited by this paper
• The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.

  1997cited by this paper
• High heterogeneity for cystic fibrosis in Spanish families: 75 mutations account for 90% of chromosomes

  1997cited by this paper
• Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells.

  1997cited by this paper
• Cystic fibrosis mutations in Romania

  1997influential reference
• Genotype-phenotype correlation in cystic fibrosis patients compound heterozygous for the A455E mutation

  1997cited by this paper
• CFTR Gene Mutations in Adults with Disseminated Bronchiectasis

  1997cited by this paper
• Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations

  1996cited by this paper
• Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor

  1996cited by this paper
• CFTR gene variant IVS8-5T in disseminated bronchiectasis.

  1996cited by this paper
• CFTR gene variant for patients with congenital absence of vas deferens.

  1995cited by this paper
• Cystic fibrosis: genotypic and phenotypic variations.

  1995cited by this paper
• Clinical characteristics of 16 cystic fibrosis patients with the missense mutation R334W, a pancreatic insufficiency mutation with variable age of onset and interfamilial clinical differences

  1995cited by this paper
• Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model.

  1994cited by this paper
• Population variation of common cystic fibrosis mutations

  1994cited by this paper
• A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.

  1994cited by this paper
• Population variation of common cystic fibrosis mutations. The Cystic Fibrosis Genetic Analysis Consortium.

  1994cited by this paper
• Mutations in CFTR associated with mild-disease-form CI- channels with altered pore properties

  1993cited by this paper
• A mutation in CFTR produces different phenotypes depending on chromosomal background

  1993cited by this paper
• Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA

  1993influential reference
• Abnormal mRNA splicing resulting from three different mutations in the CFTR gene.

  1993cited by this paper
• Phenotypic intrafamilial heterogeneity in cystic fibrosis

  1993cited by this paper
• Mislocalization of ΔF508 CFTR in cystic fibrosis sweat gland

  1992cited by this paper
• Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease.

  1992cited by this paper
• The spectrum of cystic fibrosis mutations.

  1992cited by this paper
• ABC transporters: from microorganisms to man.

  1992cited by this paper
• Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland.

  1992cited by this paper
• Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene

  1991cited by this paper
• Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium.

  1991cited by this paper
• A yeast artificial chromosome contig encompassing the cystic fibrosis locus.

  1991cited by this paper
• Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

  1991cited by this paper
• Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

  1990cited by this paper
• Chromosomal region of the cystic fibrosis gene in yeast artificial chromosomes: a model for human genome mapping.

  1990cited by this paper
• Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells

  1990cited by this paper
• Identification of the cystic fibrosis gene: genetic analysis

  1989cited by this paper
• Identification of the cystic fibrosis gene: genetic analysis.

  1989cited by this paper
• Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

  1989influential reference

• Persistent delay in maturation of the developing gut microbiota in infants with cystic fibrosis

  2025cites this paper
• Molecular mechanisms and pathological implications of unconventional protein secretion in human disease: from cellular stress to therapeutic targeting

  2025cites this paper
• Cellular signalling

  2025cites this paper
• Research Progress of the Relationship between Phenotypic Variability and Modifier Genes in Cystic Fibrosis

  2024cites this paper
• CFTR complex alleles and phenotypic variability in cystic fibrosis disease.

  2024cites this paper
• More evidence for widespread antagonistic pleiotropy in polymorphic disease alleles

  2024cites this paper
• Impact of highly effective modulator therapy on gastrointestinal symptoms and features in people with cystic fibrosis.

  2024cites this paper
• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).

  2023cites this paper
• The landscape of tolerated genetic variation in humans and primates

  2023cites this paper
• Persistent delay in maturation of the developing gut microbiota in infants with cystic fibrosis

  2023cites this paper
• Additional evidence on the phenotype produced by combination of CFTR 1677delTA alleles and their relevance in causing CFTR-related disease

  2023cites this paper
• A narrative review on the role of genetics in children with acute recurrent pancreatitis and chronic pancreatitis

  2023cites this paper
• The landscape of tolerated genetic variation in humans and primates.

  2023cites this paper
• Generation of an induced pluripotent stem cell line (IGGi002A) from nasal cells of a cystic fibrosis patient homozygous for the G542X-CFTR mutation.

  2023cites this paper
• Genetic testing of sperm donors at a human sperm bank in China

  2022cites this paper
• Losartan ameliorates TGF-β1–induced CFTR dysfunction and improves correction by cystic fibrosis modulator therapies

  2022cites this paper
• Genotype-phenotype correlations of cystic fibrosis in siblings compound heterozygotes for rare variant combinations: Review of literature and case report

  2022cites this paper
• The Human Respiratory Microbiome: Current Understandings and Future Directions

  2022cites this paper
• Modifier Factors of Cystic Fibrosis Phenotypes: A Focus on Modifier Genes

  2022cites this paper
• Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis

  2022cites this paper
• Genetic Evaluation of Pancreatitis.

  2022cites this paper
• Molecular targets for cystic fibrosis and therapeutic potential of monoclonal antibodies

  2022cites this paper
• Cystic fibrosis transmembrane conductance regulator function in patients with chronic pancreatitis

  2022cites this paper
• Synthesis Of Molecular Probes For Cystic Fibrosis Research

  2021influential citation
• A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lung

  2021cites this paper
• Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases.

  2021cites this paper
• Autophagy in major human diseases

  2021cites this paper
• Inferred inactivation of the CFTR gene in the duodena of mice exposed to hexavalent chromium (Cr(VI)) in drinking water supports its tumor-suppressor status and implies its potential role in Cr(VI)-induced carcinogenesis of the small intestines.

  2021cites this paper
• Genetic burden linked to founder effects in Saguenay–Lac-Saint-Jean illustrates the importance of genetic screening test availability

  2021cites this paper
• Trikafta therapy alters the CF lung mucus metabolome reshaping microbiome niche space

  2021cites this paper
• The Bactericidal Tandem Drug, AB569: How to Eradicate Antibiotic-Resistant Biofilm Pseudomonas aeruginosa in Multiple Disease Settings Including Cystic Fibrosis, Burns/Wounds and Urinary Tract Infections

  2021cites this paper
• Causes of Exocrine Pancreatic Insufficiency Other Than Chronic Pancreatitis

  2021cites this paper
• Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors

  2021cites this paper
• Severe and Early Hepatic Failure in A Neonate: A New CFTR Mutation Associated with Medium-Chain Acyl-CoA Deficiency

  2021cites this paper
• Electronic health record phenotypes associated with genetically regulated expression of CFTR and application to cystic fibrosis

  2020cites this paper
• Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis

  2020cites this paper
• CFTR Carrier Status

  2020cites this paper
• Cystic Fibrosis: Clinical and Diagnosis Approach

  2020cites this paper
• Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways

  2020cites this paper
• Endocrine, nutritional, and metabolic diseases

  2020cites this paper
• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).

  2020cites this paper
• Current Treatment Options for Cystic Fibrosis-Related Liver Disease

  2020cites this paper
• CFTR and Cystic Fibrosis: A Need for Personalized Medicine

  2020cites this paper
• DIBI, a novel polymeric iron chelator modulates IL-6 and IL-8 secretion from Cystic Fibrosis airway epithelial cells in response to endotoxin induction

  2020cites this paper
• Targeting chloride transport in autosomal dominant polycystic kidney disease.

  2020cites this paper
• The era of CFTR modulators: improvements made and remaining challenges

  2020cites this paper
• Carriers of cystic fibrosis among sperm donors: complete CFTR gene analysis versus CFTR genotyping.

  2020cites this paper
• In silico prediction and validation of potential therapeutic genes in pancreatic β-cells associated with type 2 diabetes

  2020cites this paper
• Diseases of the Pancreas Involving Channels/Transporters

  2020cites this paper
• Diagnosis of Etiology in Acute Pancreatitis

  2020cites this paper
• Engineered mutant α-ENaC subunit mRNA delivered by lipid nanoparticles reduces amiloride currents in cystic fibrosis–based cell and mice models

  2020cites this paper
• Tezacaftor and ivacaftor for the treatment of cystic fibrosis

  2020cites this paper
• Reproductive system status and the algorithm to solve fertility issues in men with cystic fibrosis

  2019cites this paper
• ATORVASTATIN INDUCED ACUTE PANCREATITIS? - A RARE CASE REPORT

  2019cites this paper
• Development of lentiviral airway gene therapy aerosol delivery techniques for cystic fibrosis

  2019cites this paper
• Marine Bacteria, A Source for Alginolytic Enzyme to Disrupt Pseudomonas aeruginosa Biofilms

  2019cites this paper
• Antagonistic Pleiotropy in Human Disease

  2019cites this paper
• Cystic fibrosis and exocrine pancr ea tic insuf c iency

  2019cites this paper
• Coexistence of Candida species and bacteria in patients with cystic fibrosis

  2019cites this paper
• Prevalence of Cystic Fibrosis Trans-membrane Conductance Regulator Gene common mutations in children with cystic fibrosis in Isfahan, Iran

  2019cites this paper
• Состояние репродуктивной системы и алгоритм решения вопроса деторождения у мужчин с муковисцидозом

  2019cites this paper
• Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis

  2019cites this paper
• Cystic Fibrosis–Related Diabetes: Pathophysiology and Therapeutic Challenges

  2019cites this paper
• بیماری فیبروز کیستیک و پراکندگی و آنالیز جهشهای ژن CFTRدر بیماران ایرانی

  2019cites this paper
• Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.

  2019cites this paper
• A case report of cystic fibrosis with von Willebrand disease Kistik fibrozis ile von Willebrand hastalığı birlikteliği olan bir olgu sunumu

  2019cites this paper
• Cystic fibrosis transmembrane conductance regulator—emerging regulator of cancer

  2018cites this paper
• Exophiala dermatitidis Revealing Cystic Fibrosis in Adult Patients with Chronic Pulmonary Disease

  2018cites this paper
• Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract

  2018cites this paper
• The long and winding road: stem cells for cystic fibrosis

  2018cites this paper
• Reappraisal of Frequency of Common Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations in Iranian Cystic Fibrosis Patients

  2018cites this paper
• A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies

  2018cites this paper
• Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype

  2018cites this paper
• Investigating the Role of Genetic Background and Niche of Origin in the Adaptation of Pseudomonas aeruginosa

  2018cites this paper
• IBBJ Spring 2016 , Vol 2 , No 2 Mutation and Rare Polymorphisms Insight in Exons 7 and 20 of CFTR Gene in Non-Caucasian Cystic Fibrosis Patients

  2018cites this paper
• Clinical Trials Of Glutathione Intended To Prevent The Outcomes Of Cystic Fibrosis And The Emerging Role Of GSH Precursors In Health Care And Therapeutics

  2018cites this paper
• The Role of Genetics in Pancreatitis.

  2018cites this paper
• Hyponatremic dehydration and metabolic alkalosis as dominant manifestation in cystic fibrosis infants with mild phenotype - a case series

  2018cites this paper
• Spectrum of mutations of cystic fibrosis in the 22 Arab countries: A systematic review

  2018cites this paper
• CFTR Mutation Analysis in Western Iran: Identification of Two Novel Mutations

  2018cites this paper
• Bullying and Mental Health Amongst Australian Children and Young People With Cystic Fibrosis

  2018cites this paper
• Recurrent Acute Pancreatitis: International State-of-the-Science Conference With Recommendations.

  2018cites this paper
• Recent Progress in the Discovery and Development of Small-Molecule Modulators of CFTR.

  2018cites this paper
• Développement et vectorisation de peptides inhibiteurs du domaine PDZ de CAL pour le traitement de la mucoviscidose

  2018cites this paper
• Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression

  2017cites this paper
• CFTR is involved in the regulation of glucagon secretion in human and rodent alpha cells

  2017cites this paper
• Microbiome in the pathogenesis of cystic fibrosis and lung transplant‐related disease

  2017cites this paper
• Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.

  2017cites this paper
• IBBJ Spring 2015 , Vol 1 , No 2 Molecular Screening of R 117 H ( c . 350 G > A ; p . Arg 117 His ) Mutation in Non Caucasian Cystic Fibrosis Patients from North of Iran

  2017cites this paper
• A potentially crucial role of the PKD1 C-terminal tail in renal prognosis

  2017cites this paper
• The Sweat Metabolome of Screen-Positive Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport

  2017cites this paper
• CFTR Protein Function Modulation Therapy Is Finally Targeting Cystic Fibrosis-related Gastrointestinal Disease.

  2017cites this paper
• The importance of the M 470 V polymorphism M 470 V polimorfizminin önemi

  2017cites this paper
• Small Molecule Biofilm Inhibitors with Antivirulence Properties against Pseudomonas aeruginosa

  2017cites this paper
• The molecular analysis of mutations in exons 4, 11 and 21 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in cystic fibrosis patients in Kermanshah, Iran

  2017cites this paper
• A New Targeted CFTR Mutation Panel Based on Next-Generation Sequencing Technology.

  2017cites this paper
• Refractory Chronic Rhinosinusitis with Nasal Polyposis.

  2017cites this paper
• Estudio de la microbiota de vías respiratorias en pacientes pediátricos con fibrosis quística mediante secuenciación masiva y su relación con distintas variables clínicas

  2017cites this paper
• Molecular Diagnosis of Cystic Fibrosis

  2017cites this paper
• Advanced Modelling Strategies: Challenges and pitfalls in robust causal inference with observational data

  2017cites this paper